Acurx Pharmaceuticals (ACXP)
(Delayed Data from NSDQ)
$4.28 USD
-0.27 (-5.93%)
Updated Oct 6, 2025 04:00 PM ET
After-Market: $4.26 -0.02 (-0.47%) 7:46 PM ET
2-Buy of 5 2
F Value B Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Acurx Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ACXP 4.28 -0.27(-5.93%)
Will ACXP be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ACXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACXP
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year?
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
ACXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Other News for ACXP
ACXP forms Boomer Buy Setup on October 3
ACXP forms Non-ADX 1,2,3,4 Bearish on October 2
Bollinger Band Squeeze appears for ACXP after 7.23% move
Is ACXP signaling a buying opportunity? 20 Day Moving Average Support shows up after climbing 0.23%
ACXP: HC Wainwright & Co. Reiterates Buy Rating with $31 Price Target | ACXP Stock News